Carpetimycin B is a natural antibiotic compound that belongs to the class of polyketides, which are characterized by their complex structures and diverse biological activities. It is produced by certain strains of the bacterium *Streptomyces*, known for their ability to synthesize a wide range of bioactive metabolites. Carpetimycin B exhibits antibacterial properties, making it of interest in the field of medicinal chemistry and drug development. The compound's mechanism of action typically involves inhibition of bacterial cell wall synthesis or interference with protein synthesis, although specific details may vary. Its structure features multiple functional groups that contribute to its biological activity and solubility. As with many natural products, the potential for resistance development in target bacteria is a consideration in its therapeutic application. Research into carpetimycin B continues to explore its efficacy, safety, and potential uses in treating bacterial infections, particularly those caused by resistant strains. Further studies may also investigate its pharmacokinetics and optimal formulations for clinical use.

carpetimycin B

76094-36-5: Carpetimycin B is a natural antibiotic compound that belongs to the class of polyketides, which are characterized by their complex structures and diverse biological activities. It is produced by certain strains of the bacterium *Streptomyces*, known for their ability to synthesize a wide range of bioactive metabolites. Carpetimycin B exhibits antibacterial properties, making it of interest in the field of medicinal chemistry and drug development. The compound's mechanism of action typically involves inhibition of bacterial cell wall synthesis or interference with protein synthesis, although specific details may vary. Its structure features multiple functional groups that contribute to its biological activity and solubility. As with many natural products, the potential for resistance development in target bacteria is a consideration in its therapeutic application. Research into carpetimycin B continues to explore its efficacy, safety, and potential uses in treating bacterial infections, particularly those caused by resistant strains. Further studies may also investigate its pharmacokinetics and optimal formulations for clinical use.

<p>Carpetimycin B exhibits potent activity against both Gram-positive and Gram-negative bacteria, including those that produce β-lactamase. Carpetimycin B is also a strong inhibitor of β-lactamase (β-lactamase).</p>

CAS 76094-36-5

carpetimycin B

Carpetimycin B

Ref: TM-TN10696